{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:32:43Z","timestamp":1791567163579,"version":"4.3.4"},"reference-count":81,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jaip.2022.02.016","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T11:44:30Z","timestamp":1645789470000},"page":"1140-1153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Eosinophilia Associated With Immune Deficiency"],"prefix":"10.1016","volume":"10","author":[{"given":"Peter","family":"Olbrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Ortiz Aljaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra F.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2022.02.016_bib1","series-title":"Cellular and Molecular Immunology","author":"Abbas","year":"2010"},{"key":"10.1016\/j.jaip.2022.02.016_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev-pathmechdis-012419-032756","article-title":"Contributions of eosinophils to human health and disease","volume":"15","author":"Klion","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jaip.2022.02.016_bib3","first-page":"81","article-title":"Practical approach to children presenting with eosinophilia and hypereosinophilia","volume":"16","author":"Costagliola","year":"2020","journal-title":"Curr Pediatr Rev"},{"key":"10.1016\/j.jaip.2022.02.016_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13223-016-0130-4","article-title":"Primary immunodeficiencies associated with eosinophilia","volume":"12","author":"Navabi","year":"2016","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.alit.2021.08.008","article-title":"Inborn errors of immunity with eosinophilia","volume":"70","author":"Okamoto","year":"2021","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2022.02.016_bib7","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jaci.2021.08.008","article-title":"Inborn errors of immunity manifesting as atopic disorders","volume":"148","author":"Vaseghi-Shanjani","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.iac.2015.05.004","article-title":"Eosinophilia associated with disorders of immune deficiency or immune dysregulation","volume":"35","author":"Williams","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2022.02.016_bib9","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41409-021-01378-8","article-title":"EBMT\/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity","volume":"56","author":"Lankester","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaip.2022.02.016_bib10","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2008.09.037","article-title":"Omenn syndrome: inflammation in leaky severe combined immunodeficiency","volume":"122","author":"Villa","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib11","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1182\/blood.V98.6.1847","article-title":"Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients","volume":"98","author":"M\u00fcller","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2022.02.016_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1442-200X.2012.03722.x","article-title":"Clinical and immunophenotypic features of atypical complete DiGeorge syndrome","volume":"55","author":"Vu","year":"2013","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jaip.2022.02.016_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10875-019-00717-1","article-title":"A\u00a0large cohort of RAG1\/2-deficient SCID patients-clinical, immunological, and prognostic analysis","volume":"40","author":"Greenberg-Kushnir","year":"2020","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib14","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1056\/NEJMoa0905506","article-title":"Combined immunodeficiency associated with DOCK8 mutations","volume":"361","author":"Zhang","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.02.016_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10875-014-0126-0","article-title":"DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients","volume":"35","author":"Aydin","year":"2015","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib16","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jaci.2014.12.1945","article-title":"The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency","volume":"136","author":"Engelhardt","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib17","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/s41590-020-0795-1","article-title":"Migration-induced cell shattering due to DOCK8 deficiency causes a type 2-biased helper T cell response","volume":"21","author":"Schneider","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib18","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jaip.2018.10.035","article-title":"Hematopoietic stem cell transplantation as treatment for patients with DOCK8 deficiency","volume":"7","author":"Aydin","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.02.016_bib19","article-title":"Hematopoietic stem cell transplant effectively rescues lymphocyte differentiation and function in DOCK8-deficient patients","volume":"5","author":"Pillay","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaip.2022.02.016_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/TACG.S58444","article-title":"Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments","volume":"7","author":"Buchbinder","year":"2014","journal-title":"Appl Clin Genet"},{"key":"10.1016\/j.jaip.2022.02.016_bib21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/TACG.S213920","article-title":"Autoimmunity in Wiskott-Aldrich Syndrome: updated perspectives","volume":"14","author":"Sudhakar","year":"2021","journal-title":"Appl Clin Genet"},{"key":"10.1016\/j.jaip.2022.02.016_bib22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3389\/fped.2019.00451","article-title":"Wiskott-Aldrich syndrome (WAS) and Dedicator of Cytokinesis 8 (DOCK8) deficiency","volume":"7","author":"Albert","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2022.02.016_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jaci.2018.04.017","article-title":"Screening for Wiskott-Aldrich syndrome by flow cytometry","volume":"142","author":"Chiang","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib24","doi-asserted-by":"crossref","first-page":"14816","DOI":"10.1038\/ncomms14816","article-title":"Loss of the Arp2\/3 complex component ARPC1B causes platelet abnormalities and predisposes to inflammatory disease","volume":"8","author":"Kahr","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaip.2022.02.016_bib25","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.jaci.2019.02.003","article-title":"A\u00a0combined immunodeficiency with severe infections, inflammation, and\u00a0allergy caused by ARPC1B deficiency","volume":"143","author":"Volpi","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib26","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.02.016_bib27","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2022.02.016_bib28","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1067\/mpd.2002.127503","article-title":"Cutaneous manifestations of hyper-IgE syndrome in infants and children","volume":"141","author":"Chamlin","year":"2002","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2022.02.016_bib29","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1101\/gr.131029.111","article-title":"Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis","volume":"22","author":"Kong","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.jaip.2022.02.016_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1155\/2010\/580197","article-title":"Clinical manifestations of hyper IgE syndromes","volume":"29","author":"Freeman","year":"2010","journal-title":"Dis Markers"},{"key":"10.1016\/j.jaip.2022.02.016_bib31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ccm.2016.04.016","article-title":"Hyper-IgE syndromes and the lung","volume":"37","author":"Freeman","year":"2016","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jaip.2022.02.016_bib32","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jaci.2015.07.003","article-title":"Endemic mycoses in patients with STAT3-mutated hyper-IgE (Job) syndrome","volume":"136","author":"Odio","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib33","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jaci.2013.08.045","article-title":"Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation","volume":"132","author":"Siegel","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib34","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10875-017-0429-z","article-title":"Gastrointestinal manifestations of STAT3-deficient hyper-IgE syndrome","volume":"37","author":"Arora","year":"2017","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib35","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","article-title":"Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey","volume":"91","author":"Chandesris","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2022.02.016_bib36","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s10875-021-00971-2","article-title":"Hematopoietic stem cell transplantation resolves the immune deficit associated with STAT3-dominant-negative hyper-IgE syndrome","volume":"41","author":"Harrison","year":"2021","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.coi.2021.04.007","article-title":"Inborn errors of IL-6 family cytokine responses","volume":"72","author":"Chen","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat4956","article-title":"A\u00a0recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity","volume":"3","author":"B\u00e9ziat","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib39","article-title":"Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome","volume":"217","author":"B\u00e9ziat","year":"2020","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2022.02.016_bib40","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1084\/jem.20161810","article-title":"A\u00a0biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis","volume":"214","author":"Schwerd","year":"2017","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2022.02.016_bib41","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3324\/haematol.2018.194233","article-title":"Selective LOF variants in IL6ST cause hyper-IgE syndrome with distinct impairments of T-cell phenotype and function","volume":"104","author":"Shahin","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jaip.2022.02.016_bib42","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1084\/jem.20190344","article-title":"Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses","volume":"216","author":"Spencer","year":"2019","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2022.02.016_bib43","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20161435","article-title":"ERBIN deficiency links STAT3 and TGF-\u03b2 pathway defects with atopy in humans","volume":"214","author":"Lyons","year":"2017","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2022.02.016_bib44","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-3-030-80614-9_11","article-title":"Loeys-Dietz syndrome","volume":"1348","author":"Velchev","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jaip.2022.02.016_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006448","article-title":"TGF\u03b2 receptor mutations impose a strong predisposition for human allergic disease","volume":"5","author":"Frischmeyer-Guerrerio","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaip.2022.02.016_bib46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jaci.2015.07.047","article-title":"Neonatal-onset T(\u2013)B(\u2013)NK(+) severe combined immunodeficiency and neutropenia caused by mutated phosphoglucomutase 3","volume":"137","author":"Bernth-Jensen","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib47","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/jbmr.3173","article-title":"A\u00a0novel PGM3 mutation is associated with a severe phenotype of bone marrow failure, severe combined immunodeficiency, skeletal dysplasia, and congenital malformations","volume":"32","author":"Pacheco-Cu\u00e9llar","year":"2017","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jaip.2022.02.016_bib48","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jaci.2014.02.025","article-title":"Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels","volume":"133","author":"Sassi","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib49","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ajhg.2014.05.007","article-title":"PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia","volume":"95","author":"Stray-Pedersen","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaip.2022.02.016_bib50","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jaci.2014.02.013","article-title":"Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment","volume":"133","author":"Zhang","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib51","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jaci.2018.08.013","article-title":"Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease","volume":"143","author":"Dorjbal","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib52","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/ng.3898","article-title":"Germline hypomorphic CARD11 mutations in severe atopic disease","volume":"49","author":"Ma","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2022.02.016_bib53","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jaci.2013.02.012","article-title":"Whole-exome sequencing links caspase recruitment domain 11 (CARD11) inactivation to severe combined immunodeficiency","volume":"131","author":"Greil","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib54","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1084\/jem.20120831","article-title":"Congenital B cell lymphocytosis explained by novel germline CARD11 mutations","volume":"209","author":"Snow","year":"2012","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2022.02.016_bib55","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jaci.2015.06.031","article-title":"Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: molecular, immunologic, and clinical heterogeneity","volume":"136","author":"P\u00e9rez de Diego","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib56","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jaci.2014.06.015","article-title":"The CARD11-BCL10-MALT1 (CBM) signalosome complex: stepping into the limelight of human primary immunodeficiency","volume":"134","author":"Turvey","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib57","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1525-1470.2008.00663.x","article-title":"Netherton syndrome and trichorrhexis invaginata--a novel diagnostic approach","volume":"25","author":"Burk","year":"2008","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaip.2022.02.016_bib58","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00441-013-1558-1","article-title":"Netherton syndrome: skin inflammation and allergy by loss of protease inhibition","volume":"351","author":"Hovnanian","year":"2013","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.jaip.2022.02.016_bib59","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jaci.2009.06.009","article-title":"Com\u00e8l-Netherton syndrome defined as primary immunodeficiency","volume":"124","author":"Renner","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib60","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jaci.2017.10.041","article-title":"Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study","volume":"141","author":"Barzaghi","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib61","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.jaip.2020.04.070","article-title":"Clinical, immunological, and genetic features in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-like syndrome","volume":"8","author":"Jamee","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.02.016_bib62","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/1744666X.2018.1531704","article-title":"STAT1 and STAT3 mutations: important lessons for clinical immunologists","volume":"14","author":"Olbrich","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib63","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.jaci.2016.12.957","article-title":"JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome","volume":"139","author":"Del Bel","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib64","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.immuni.2020.07.006","article-title":"Complex autoinflammatory syndrome unveils fundamental principles of JAK1 kinase transcriptional and biochemical function","volume":"53","author":"Gruber","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2022.02.016_bib65","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s10875-017-0433-3","article-title":"Adenosine deaminase (ADA)-deficient severe combined immune deficiency (SCID): molecular pathogenesis and clinical manifestations","volume":"37","author":"Bradford","year":"2017","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib66","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s10875-018-0496-9","article-title":"ADA deficiency: evaluation of the clinical and laboratory features and the outcome","volume":"38","author":"Cagdas","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib67","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jaci.2013.05.040","article-title":"Elevated IgE and atopy in patients treated for early-onset ADA-SCID","volume":"132","author":"Lawrence","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib68","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jaci.2018.08.024","article-title":"Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency","volume":"143","author":"Kohn","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib69","doi-asserted-by":"crossref","first-page":"12614","DOI":"10.1073\/pnas.221456898","article-title":"Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM","volume":"98","author":"Ferrari","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2022.02.016_bib70","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3892\/etm.2015.2261","article-title":"X-linked hyper-IgM syndrome with eosinophilia in a male child: a case report","volume":"9","author":"Guo","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jaip.2022.02.016_bib71","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1067\/mpd.2003.41","article-title":"Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency","volume":"142","author":"Kutukculer","year":"2003","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2022.02.016_bib72","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.aller.2019.08.005","article-title":"CD40 Ligand deficiency","volume":"48","author":"Leite","year":"2020","journal-title":"Allergol Immunopathol"},{"key":"10.1016\/j.jaip.2022.02.016_bib73","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.jaci.2018.12.1010","article-title":"Hematopoietic stem cell transplantation for CD40 ligand deficiency: results from an EBMT\/ESID-IEWP-SCETIDE-PIDTC study","volume":"143","author":"Ferrua","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib74","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00431-008-0718-x","article-title":"Clinical heterogeneity can hamper the diagnosis of patients with ZAP70 deficiency","volume":"168","author":"Turul","year":"2009","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaip.2022.02.016_bib75","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jaci.2014.06.001","article-title":"MHC class I and II deficiencies","volume":"134","author":"Hanna","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib76","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1002\/ajmg.a.62378","article-title":"Spondyloepimetaphyseal dysplasia EXTL3-deficient type: long-term follow-up and review of the literature","volume":"185","author":"Akal\u0131n","year":"2021","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jaip.2022.02.016_bib77","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/pai.13535","article-title":"Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: a systematic review","volume":"32","author":"Hafezi","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib78","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3389\/fimmu.2021.671755","article-title":"Primary immune regulatory disorders with an autoimmune lymphoproliferative syndrome-like phenotype: immunologic evaluation, early diagnosis and management","volume":"12","author":"L\u00f3pez-Nevado","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2022.02.016_bib79","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ajh.20851","article-title":"Eosinophilia is associated with a higher mortality rate among patients with autoimmune lymphoproliferative syndrome","volume":"82","author":"Kim","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaip.2022.02.016_bib80","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(04)17552-1","article-title":"Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies","volume":"364","author":"Dorman","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.02.016_bib81","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202726","article-title":"High Th2 cytokine levels and upper airway inflammation in human inherited T-bet deficiency","volume":"218","author":"Yang","year":"2021","journal-title":"J\u00a0Exp Med"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822001805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822001805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:32:21Z","timestamp":1761975141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219822001805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2213219822001805"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2022.02.016","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eosinophilia Associated With Immune Deficiency","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2022.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}